Earnings summaries and quarterly performance for HEALTHPEAK PROPERTIES.
Executive leadership at HEALTHPEAK PROPERTIES.
Scott M. Brinker
President and Chief Executive Officer
Adam G. Mabry
Chief Investment Officer
Ankit B. Patadia
Executive Vice President and Treasurer – Corporate Finance
Kelvin O. Moses
Chief Financial Officer
Lisa A. Alonso
Executive Vice President and Chief Human Resources Officer
Scott R. Bohn
Chief Development Officer and Head of Lab
Shawn G. Johnston
Executive Vice President and Chief Accounting Officer
Tracy A. Porter
Executive Vice President and General Counsel
Board of directors at HEALTHPEAK PROPERTIES.
Ava E. Lias-Booker
Independent Director
Brian G. Cartwright
Independent Director
Governor Tommy G. Thompson
Independent Director
James B. Connor
Independent Director
John T. Thomas
Vice Chair of the Board
Katherine M. Sandstrom
Independent Chair of the Board
Pamela J. Kessler
Independent Director
R. Kent Griffin, Jr.
Independent Director
Richard A. Weiss
Independent Director
Sara G. Lewis
Independent Director
Research analysts who have asked questions during HEALTHPEAK PROPERTIES earnings calls.
Austin Wurschmidt
KeyBanc Capital Markets Inc.
4 questions for DOC
Farrell Granath
Bank of America
4 questions for DOC
Juan Sanabria
BMO Capital Markets
4 questions for DOC
Michael Carroll
RBC Capital Markets
4 questions for DOC
Michael Stroyeck
Green Street Advisors, LLC
4 questions for DOC
Ronald Kamdem
Morgan Stanley
4 questions for DOC
Vikram Malhotra
Mizuho Financial Group, Inc.
4 questions for DOC
Wesley Golladay
Robert W. Baird & Co.
4 questions for DOC
Jamie Feldman
Wells Fargo & Company
2 questions for DOC
John Pawlowski
Green Street
2 questions for DOC
Jon Petersen
Jefferies
2 questions for DOC
Michael Mueller
JPMorgan Chase & Co.
2 questions for DOC
Mike Mueller
JPMorgan Chase & Co.
2 questions for DOC
Nicholas Yulico
Scotiabank
2 questions for DOC
Nick Joseph
Citigroup Inc.
2 questions for DOC
Nick Yulico
Scotiabank
2 questions for DOC
Omotayo Okusanya
Deutsche Bank AG
2 questions for DOC
Richard Anderson
Wedbush Securities
2 questions for DOC
Seth Bergey
Citi
2 questions for DOC
Recent press releases and 8-K filings for DOC.
- Healthpeak Properties reported FFO as adjusted of $0.46 per share and AFFO of $0.42 per share for Q3 2025, with year-to-date portfolio same-store growth at 3.8%.
- The company plans to generate $1 billion or more from outpatient medical asset sales, with $204 million already under purchase and sale agreement, intending to recycle these proceeds into higher-return lab opportunities (targeting double-digit unlevered IRRs) and outpatient development (average yield 7+%).
- Outpatient medical leasing was strong in Q3 2025, with 1.2 million square feet executed, achieving positive cash releasing spreads of 5.4% and ending the quarter with 91% occupancy.
- In the lab sector, the leasing pipeline has doubled to 1.8 million square feet since Q1 2025; however, occupancy is expected to decline to the high 70% range over the next couple of quarters before recovering, with earnings benefits starting in late 2026 and thereafter.
- The company reaffirmed its FFO as adjusted and same-store expectations within its original guidance range and reduced interest expense and G&A guidance by $10 million.
- Healthpeak Properties reported Q3 2025 FFO as adjusted of $0.46 per share and AFFO of $0.42 per share, with year-to-date portfolio same-store growth of 3.8%.
- The company plans to generate $1 billion or more from outpatient medical asset sales, with $130 million already under signed contract, to recycle into higher-return lab opportunities and outpatient development. This strategy is expected to create meaningful accretion.
- Leading indicators in the lab sector are positive, with the leasing pipeline doubling since the start of the year. However, lab occupancy is projected to decline to the high 70% range over the next few months before an anticipated recovery.
- Healthpeak has internalized property management on 39 million sq ft and is implementing technology initiatives to enhance operations.
- Healthpeak (DOC) reported Q3 2025 FFO as adjusted of $0.46 per share and AFFO of $0.42 per share, with year-to-date portfolio same-store growth of 3.8%.
- The company plans to generate $1,000,000,000 or more from selling less core real estate, with proceeds intended for recycling into higher-return lab opportunities.
- The CCRC and Outpatient Medical segments showed strong performance, with CCRC Cash NOI increasing 9.4% and Outpatient Medical achieving 5.4% positive cash re-leasing spreads and 91% occupancy in Q3 2025.
- The Lab segment's occupancy was 81% in Q3 2025, with the leasing pipeline doubling to 1,800,000 square feet since Q1 2025, though occupancy is expected to decline for a few more months before recovery, impacting 2026 earnings.
- Healthpeak maintains a strong balance sheet, ending Q3 2025 with $2,700,000,000 of liquidity and net debt to adjusted EBITDA at 5.3x.
- Healthpeak Properties reported Q3 2025 FFO as adjusted of $0.46 per share and AFFO of $0.42 per share, with year-to-date portfolio same-store growth of 3.8%.
- The company plans to generate $1 billion or more from selling less core outpatient medical real estate, with $204 million already under purchase and sale agreement, and intends to recycle these proceeds into higher-return lab opportunities targeting double-digit unlevered IRRs.
- Leading indicators in the life science sector are turning positive, with the leasing pipeline doubling since Q1 2025 to 1.8 million sq ft. Occupancy is expected to decline for the next few months, potentially bottoming in the high 70% range, with recovery and earnings contribution expected from late 2026.
- Healthpeak reaffirmed its FFO as adjusted and same-store expectations, reducing interest expense and G&A guidance by $10 million, and maintains a strong balance sheet with $2.7 billion of liquidity.
- On August 14, 2025, Healthpeak OP, LLC, a subsidiary of Healthpeak Properties, Inc., completed an underwritten offering of $500.0 million aggregate principal amount of its 4.750% senior notes due 2033.
- The estimated net proceeds from the offering are approximately $491.4 million.
- Healthpeak OP intends to use the net proceeds to repay borrowings outstanding under its commercial paper program and for general corporate purposes.
- The notes will mature on January 15, 2033, and interest will be paid semi-annually on January 15 and July 15, beginning on January 15, 2026.
- The notes are fully and unconditionally guaranteed on a joint and several basis by Healthpeak Properties, Inc., DOC DR Holdco, LLC, and DOC DR, LLC.
- Healthpeak reported strong financial results for Q2 2025, leading to the reaffirmation of FFO as adjusted and same store cash NOI expectations.
- The outpatient medical segment achieved near record levels for same store growth, retention, and releasing spreads, while the CCRC portfolio saw record leasing volumes and 50% higher annual NOI than pre-pandemic levels.
- Despite an occupancy decline in the lab R&D business due to tenant capital raising challenges, leading indicators are turning positive, including a reduction in spec new supply and recent M&A deals.
- The company maintains a strong balance sheet with $2.3 billion of liquidity and continues to prioritize balance sheet discipline and opportunistic capital allocation. Regulatory changes, such as a proposed CMS rule to reverse the inpatient-only list, are expected to be positive for the business.
- Healthpeak Properties, Inc. reported Q1 2025 financial results with net income per common share of $0.06, Nareit FFO of $0.45 per share, FFO as Adjusted of $0.46 per share, and AFFO of $0.43 per share.
- The company declared a monthly cash dividend of $0.10167 per share (annualized to $1.22 per share) for Q2 and executed share repurchase activity, repurchasing approximately 5.1 million shares at a weighted average price of $18.50.
- Operational highlights include executing 1.2 million square feet in new and renewal leases, forming a long-term partnership with Hines for the multifamily component of Cambridge Point, and maintaining approximately $2.8 billion in available liquidity.
- Kelvin Moses is named Chief Financial Officer of Healthpeak Properties, effective immediately as of April 24, 2025.
- Moses, previously serving as Executive Vice President – Investments and Portfolio Management, brings extensive experience including leading a $5 billion merger integration.
- Peter Scott resigned as CFO on April 2, 2025 to assume the CEO role at Healthcare Realty Trust, marking a notable leadership transition.
- The company confirmed his departure was voluntary, with no severance entitlement, and indicated that an internal successor will be named soon as part of its succession plan.
Quarterly earnings call transcripts for HEALTHPEAK PROPERTIES.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more